Received Dose and Dose-Intensity of Chemotherapy and Outcome in Nonmetastatic Extremity Osteosarcoma

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1982 • 1,079 citations

The importance of dose intensity in chemotherapy of metastatic breast cancer.

1984 • 882 citations

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

1990 • 657 citations

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.

1987 • 528 citations

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.

1986 • 454 citations

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

1997 • 378 citations

Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.

1984 • 353 citations

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.

1992 • 315 citations

Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.

1991 • 209 citations

Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma

1991 • 206 citations

Interferon alfa-2b in the treatment of chronic myelogenous leukemia.

1987 • 125 citations

The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.

1991 • 118 citations

Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors.

1997 • 108 citations

Osteosarcoma of the limbs.Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation

1988 • 88 citations

Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease.

1989 • 75 citations

Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.

1982 • 62 citations

Influence of Adriamycin Dose in the Outcome of Patients with Osteosarcoma Treated with Multidrug Neoadjuvant Chemotherapy: Results of Two Sequential Studies

1993 • 40 citations

Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup.

1994 • 32 citations

The dilemma of adjuvant chemotherapy for osteogenic sarcoma.

1980 • 29 citations

Methotrexate Serum Concentration and Histological Response to Multiagent Primary Chemotherapy for Osteosarcoma of the Limbs

1996 • 26 citations

Haemopoietic growth factors and dose intensity in high-grade and intermediate-grade lymphoma

1994 • 19 citations

A trial of chemotherapy in patients with osteosarcoma

1986 • 16 citations

Intraperitoneal-administered carboplatin in patients with ovarian cancer; influence of a dwell-time on toxicity and response

1994 • 12 citations

Cited By (0)

Loading...